Last reviewed · How we verify
flavonoid-based supplements
At a glance
| Generic name | flavonoid-based supplements |
|---|---|
| Sponsor | University of Roma La Sapienza |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases. (NA)
- Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia (PHASE2)
- Design and Development of a Novel Food Supplement for Osteoporosis Based on Gut Microbiome Mechanisms (NA)
- Irritation and Anal Bleeding in Patients Affected by Hemorrhoids. (PHASE4)
- Soy Supplementation and Gestational Diabetes (EARLY_PHASE1)
- Effect of Revival Soy on Fibromyalgia Pain (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- flavonoid-based supplements CI brief — competitive landscape report
- flavonoid-based supplements updates RSS · CI watch RSS
- University of Roma La Sapienza portfolio CI